Skip to main content
Advertisement
Advertisement

EVO

EVO logo

Evotec SE - ADR

1.60
USD
Sponsored
-0.04
-2.74%
Oct 02, 15:59 UTC -4
Closed
exchange

Pre-Market

1.65

+0.04
+2.81%

EVO Earnings Reports

Positive Surprise Ratio

EVO beat 16 of 40 last estimates.

40%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$130.29M
/
-$0.34
Implied change from Q2 26 (Revenue/ EPS)
-9.19%
/
+30.77%
Implied change from Q3 25 (Revenue/ EPS)
-20.50%
/
+183.33%

Evotec SE - ADR earnings per share and revenue

On Aug 13, 2026, EVO reported earnings of -0.26 USD per share (EPS) for Q2 26, beating the estimate of -0.38 USD, resulting in a 32.26% surprise. Revenue reached 143.48 million, compared to an expected 145.44 million, with a -1.35% difference. The market reacted with a -7.76% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 2 analysts forecast an EPS of -0.34 USD, with revenue projected to reach 130.29 million USD, implying an increase of 30.77% EPS, and decrease of -9.19% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Incannex Healthcare Limited Common Stock
Report Date
Sep 25, 2026 For Q4 26
Estimate
-$0.76
Actual
-$0.19
Surprise
+74.15%
logo
NanoViricides Inc.
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
For Q2 2026, Evotec SE - ADR reported EPS of -$0.26, beating estimates by 32.26%, and revenue of $143.48M, -1.35% below expectations.
The stock price moved down -7.76%, changed from $2.19 before the earnings release to $2.02 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on 2 analysts, Evotec SE - ADR is expected to report EPS of -$0.34 and revenue of $130.29M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement